Clinical trial
A Long-Term Registry of Humira ® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
| Category | Value |
|---|---|
| Study start date | 2013-05-03 |